Cardiorenal Protective Effects of Anti-diabetic Drugs in Early Stage Cardiovascular-Kidney-Metabolic Syndrome: A Multicenter, Time-Varying Analysis

Related

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026

• SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes

  Clinical Journal of the American Society of Nephrology · 4 Oct 2026

• GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk

  Diabetes, Obesity & Metabolism · 4 Oct 2026

• Underweight is linked to higher kidney disease risk in diabetes

  Frontiers in Endocrinology · 4 Oct 2026